Your Notifications
All done, no notifications

Transcatheter Aortic Valve Implantation Cost in Turkey

USD 1500 - USD 55000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

2
Days in Hospital
1-2 hrs
Procedure Time
95 - 98%
Success Rate
Transcatheter Aortic Valve Implantation
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 1500 - USD 55000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator

International Quality. Affordable Care.

How Much Does Transcatheter Aortic Valve Implantation (TAVI) Cost in Turkey?

The cost of Transcatheter Aortic Valve Implantation (TAVI) in Turkey ranges between USD 30000 - USD 55000, depending on the patient’s condition.

The cost of TAVI depends on various factors, including the patient’s age, severity of the condition, type of valve used, and the hospital chosen. It is advisable to discuss cost options with your healthcare provider before planning the procedure.

Factors Influencing the Cost of Transcatheter Aortic Valve Implantation (TAVI)

  • Patient's overall health: The presence of multiple medical conditions, frailty, or the need for additional monitoring can increase treatment costs more than age alone.
  • Severity of Condition: Patients with severe aortic stenosis or additional cardiac conditions may require more complex procedures, longer hospital stays, or intensive care.
  • Pre-Operative Evaluations: CT angiography, echocardiography, coronary angiography, blood investigations, and other cardiac assessments.
  • Hospital and Location: Choice of hospital, city, and associated logistics play a crucial role in determining cost.
  • Type of Valve Used: The choice of transcatheter valve (e.g., balloon-expandable or self-expanding) and the valve manufacturer significantly influence overall cost. Newer-generation and imported valves generally increase the treatment cost.
  • Additional Costs: Medications, post-operative care, and follow-up consultations add to the overall cost of treatment.

Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive procedure used to replace a severely narrowed aortic valve without open-heart surgery. It is commonly recommended for patients with severe aortic stenosis who are at intermediate or high surgical risk

What's included in your Transcatheter Aortic Valve Implantation quote?

Comprehensive evaluation
ECG, Echocardiogram, CT angiography, Coronary angiography, blood tests, and anesthesia assessment
Heart Specialists Team
Transcatheter implantation of a bioprosthetic aortic valve using a minimally invasive approach
Hospital stay + ICU as needed
ICU monitoring, cardiac observation, and pain management
Country stay monitoring
Lifestyle counselling, medication management, supervised rehabilitation, and recovery planning
Visa & medical-visa invite letter
Airport pickup & transfers

Cost of Transcatheter Aortic Valve Implantation in Major Cities of Turkey

CityCost (USD)
Ankara $30,000 – $55,000 Explore More
Antalya $30,000 – $55,000 Explore More
Bursa $30,000 – $55,000 Explore More
Istanbul $30,000 – $55,000 Explore More
Izmir $30,000 – $55,000 Explore More
Kocaeli $30,000 – $55,000 Explore More
Samsun $30,000 – $55,000 Explore More
Trabzon $27,000 – $49,500 Explore More

Transcatheter Aortic Valve Implantation - Turkey Vs the World

$22k - $32k
$25k - $45k
$30k - $50k
$30k - $55k
$35k - $65k
$40k - $70k
$40k - $70k
$45k - $65k
$45k - $75k
$50k - $85k
$55k - $90k
Dr. Shagufta Parveen
Author

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

View More
Dr. Naresh Kumar Goyal
Reviewer

Cardiologist

21 Years of Experience

Last Reviewed - June 2026

Dr. Naresh Kumar Goyal is highly trained as a cardiologist with exposure in virtually all aspects of cardiology. He qualified with an MD in internal medicine in 1999 from SMS Medical College, Jaipur, and served in the Cardiology Department as an honorary resident. From this stage, he also started with training in the temporary pacing of the pacemaker as well as interventional services.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

15 min
Average response time

Serving Patients Worldwide in Multiple Languages.

TAVI is a minimally invasive cardiac procedure used to replace a stenotic aortic valve. Instead of open-heart surgery, a catheter-based technique is used, making it a safer alternative for high-risk patients. It is particularly beneficial for elderly patients or those who cannot undergo traditional surgery.

TAVI is performed through a catheter inserted in a blood vessel (usually through the groin or chest). The new valve is delivered to the aortic position and deployed to restore normal blood flow. This procedure offers significant symptomatic relief and improves heart function.

The purpose of TAVI is to treat severe aortic stenosis, a condition in which the aortic valve narrows and prevents blood from flowing from the heart to the body. Untreated heart failure, exhaustion, chest pain, or even abrupt cardiac death may result. Particularly for older patients or those with a high surgical risk, TAVI provides a less invasive option to open heart surgery. TAVI restores normal blood flow, strengthens the heart, and improves quality of life by replacing the constricted valve.

Consult a cardiologist if you experience shortness of breath, chest tightness, light-headedness, fainting spells, or reduced ability to exercise\u2014all common symptoms of aortic stenosis. Elderly individuals or those with known valve disease should undergo regular echocardiograms to monitor valve function. Early referral is crucial once severe narrowing is diagnosed, especially in symptomatic cases.

Pre-procedure preparation involves echocardiography, CT angiography, ECG, and blood tests to evaluate heart anatomy, valve severity, and vascular access. A multidisciplinary \u201cheart team\u201d assesses patient suitability. Medications may need adjustment, and patients are generally advised to fast for 6\u20138 hours before the surgery. Antiplatelet or anticoagulant medications are reviewed, and preoperative counselling is provided to explain risks and expectations.

TAVI is performed under local anaesthesia with sedation or general anaesthesia:

  • Access Route: The most popular method is transfemoral, which entails putting a catheter into the groin's femoral artery. Depending on anatomy, additional access points can be transapical (through the chest wall) or transaortic (via a little incision in the upper chest).
  • Valve Replacement: A bioprosthetic valve is mounted on a balloon or self-expanding stent and delivered via catheter to the diseased aortic valve. Once positioned, it is expanded to push aside the native valve and take over its function.

TAVI typically takes 1 to 2 hours. Most patients are monitored in a cardiac ICU for 24\u201348 hours, and the average hospital stay is 2 to 5 days, depending on recovery and underlying health.

  • Vascular injury
  • Stroke
  • Bleeding
  • Arrhythmias or need for pacemaker
  • Valve leakage (paravalvular leak)
  • Kidney dysfunction
  • Infection
  • Rarely, valve malposition or failure

  • Significant improvement in symptoms and daily functioning
  • Lower procedural risk compared to open-heart surgery
  • Shorter hospital stay and faster recovery
  • Increased survival in high-risk and elderly patients
  • Minimally invasive\u2014no need for open chest incision

Recovery is generally fast, especially with transfemoral access. Patients may walk within a day and resume light activity in a few days. Regular follow-up visits and echocardiograms are needed to monitor valve function. Lifestyle changes, cardiac rehabilitation, and medication adjustments are often recommended to optimise heart health.

TAVI has a success rate of 95\u201398% in appropriately selected patients. It significantly reduces mortality and rehospitalisation rates in severe aortic stenosis. Most patients report a dramatic improvement in symptoms and return to independent living, especially when performed early in the course of the disease.

95-98%

5-year survival in low- to intermediate-risk patients

2-4 days

Typical hospital stay

1-2 Months

Typical recovery period before resuming most daily activities
Explore Hospitals ( 43 )

Istanbul, Turkey

252+ Beds · 229+ Procedures
JCI NABH
Starting
USD 1500

Istanbul, Turkey

170+ Beds · 257+ Procedures
JCI
Starting
USD 14000

Istanbul, Turkey

138+ Beds · 225+ Procedures
JCI
Starting
USD 30000

Get Your Transcatheter Aortic Valve Implantation
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

Free Consultation No Obligation Personalized Treatment Plan Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Mr Hailu Kassa : CABG Surgery
Mr Hailu Kassa
Mr Hailu Kassa : CABG Surgery

Mr. Hailu Kassa underwent Coronary Artery Bypass Surgery in Vejthani Hospital, Thailand under the supervision of Dr. Piya, Cardio-Thoracic Surgeon

Rod Schaubroeck
Rod Schaubroeck
Rod Schaubroeck : Double Valve Replacement

Patient Testimonial: Rod Schaubroeck from United States (U.S.A) underwent heart valve replacement at Fortis Hospital, India

Frequently Asked Questions

The cost of Transcatheter Aortic Valve Implantation (TAVI) in Turkey may vary depending on the severity of aortic valve disease, type of valve used, patient's age and overall health, pre-procedure diagnostic investigations, hospital charges, interventional cardiologist's and cardiac surgeon's fees, valve device cost, anaesthesia, medications, and length of hospital stay. The overall cost may include specialist consultations, ECG, echocardiography, CT angiography, cardiac catheterisation, blood tests, the TAVI valve and delivery system, procedure charges, postoperative monitoring, medications, and follow-up care.MediGence can help international patients explore suitable cardiac centres and obtain an estimated treatment plan based on the patient's valve condition, anatomy, and clinical requirements.

The best hospitals in Turkey for Transcatheter Aortic Valve Implantation are those with experienced structural heart specialists, interventional cardiologists, cardiac surgeons, cardiac imaging experts, cardiac anaesthesiologists, and multidisciplinary heart teams. Patients should consider hospitals with dedicated catheterisation laboratories, advanced cardiac imaging, hybrid operating rooms, cardiac intensive care units, and access to emergency cardiac surgery.Hospitals with established TAVI programmes and experience in treating complex aortic valve disease may be particularly suitable for patients requiring specialised structural heart care.

Patients should choose an interventional cardiologist or structural heart specialist experienced in TAVI and the management of aortic valve disease. Important factors include expertise in transcatheter valve implantation, pre-procedure valve assessment, CT-based procedural planning, vascular access, valve positioning, management of procedural complications, and long-term valve follow-up.The treating team should assess the severity of aortic stenosis, valve anatomy, symptoms, ventricular function, CT findings, coronary anatomy, vascular access, associated medical conditions, surgical risk, and overall health before recommending TAVI.

The success of Transcatheter Aortic Valve Implantation in Turkey varies depending on the severity of aortic valve disease, valve anatomy, patient's age, surgical risk, associated medical conditions, vascular anatomy, type of valve used, and overall clinical status. Outcomes are generally favourable when TAVI is performed in experienced structural heart centres with appropriate patient selection and multidisciplinary planning.Treatment outcomes may be assessed through successful valve implantation, improved valve function, reduced pressure gradients, symptom relief, improved exercise capacity, and quality of life. The treating cardiac team can provide a more individualised prognosis after evaluating the patient's valve anatomy and clinical condition.

Hospitals in Turkey may use transthoracic and transoesophageal echocardiography, cardiac CT angiography, coronary angiography, cardiac catheterisation, fluoroscopic imaging, advanced haemodynamic monitoring, and specialised transcatheter valve delivery systems.TAVI involves guiding a replacement aortic valve through a catheter, commonly through an artery, and positioning it within the diseased native valve. The replacement valve expands and begins functioning as the new aortic valve. The procedure is generally performed without conventional open-heart surgery and may be considered for selected patients with symptomatic aortic valve disease.

Possible risks and complications may include:
  • Bleeding or vascular injury
  • Infection
  • Abnormal heart rhythms
  • Need for permanent pacemaker implantation
  • Stroke
  • Blood clots
  • Valve leakage
  • Valve malposition
  • Coronary artery obstruction
  • Kidney injury related to contrast material
  • Cardiac perforation
  • Heart failure
  • Need for emergency surgery
  • Death in rare cases
  • The specific risks depend on the patient's age, valve anatomy, vascular condition, kidney function, associated heart disease, and overall health. The treating structural heart team will explain the potential risks and expected benefits before the procedure.

    Patients should share all relevant cardiac records with the treating structural heart team before travelling. These may include ECGs, echocardiography reports, cardiac CT angiography, coronary angiography, cardiac catheterisation reports, blood test results, previous cardiac procedure records, medication history, and allergy information.Patients should also discuss medication adjustments, including anticoagulant or antiplatelet management where applicable, expected hospital stay, procedural risks, postoperative precautions, follow-up requirements, and travel arrangements before making their plans.

    Yes. International patients can arrange an online consultation with an interventional cardiologist, structural heart specialist, or cardiac surgeon before travelling to Turkey. The specialist may review the patient's echocardiography, CT findings, coronary imaging, symptoms, previous treatment, surgical risk, and overall clinical condition to determine whether TAVI may be an appropriate treatment option.MediGence can help coordinate online consultations and facilitate the secure sharing of relevant medical records and cardiac imaging with suitable specialists.

    International patients should carry a valid passport and relevant medical documents, including:
  • ECG reports
  • Echocardiography reports
  • Cardiac CT angiography reports and images
  • Coronary angiography or catheterisation reports
  • Previous cardiac surgery or procedure records
  • Recent blood test results
  • Current prescriptions and medication details
  • Allergy and complete medical history
  • Previous cardiac imaging, if available
  • Patients should also carry digital copies of important medical records and imaging for easy access during consultations and treatment.

    The required stay in Turkey depends on the patient's cardiac condition, procedural outcome, recovery, and occurrence of complications. TAVI generally requires hospitalisation for monitoring of heart rhythm, valve function, vascular access, kidney function, and other potential complications.International patients may need to remain in Turkey until the treating team confirms stable cardiac function, satisfactory recovery, appropriate medication management, and fitness to travel. Additional follow-up may be recommended before returning home.

    Recovery after Transcatheter Aortic Valve Implantation is generally shorter than recovery after conventional open-heart aortic valve replacement. Patients may gradually resume light daily activities after discharge while following medical advice regarding physical activity and wound care.Follow-up may include clinical assessment, ECG, echocardiography, medication adjustment, and monitoring of valve function. Long-term cardiology follow-up is important to assess prosthetic valve performance, heart function, symptoms, and potential complications.

    If complications occur, patients should contact the treating cardiac team or seek immediate medical attention. Prompt evaluation may be required for chest pain, severe shortness of breath, fainting, persistent palpitations, fever, significant bleeding or swelling at the catheter insertion site, sudden weakness, or other symptoms suggesting a cardiac or vascular complication.Patients should receive detailed discharge instructions, catheter-site care guidance, medication recommendations, activity restrictions, emergency contact information, and a structured cardiac follow-up plan before returning home.

    International patients can submit their medical records, echocardiography reports, CT angiography, cardiac imaging, and previous treatment details through the MediGence website. Following an initial review, the MediGence care team can help patients explore suitable cardiac hospitals and experienced structural heart specialists, coordinate consultations, and support treatment planning and medical travel arrangements.The final treatment recommendation is made by the treating structural heart team after a comprehensive evaluation of the patient's aortic valve disease, anatomy, surgical risk, and overall clinical condition.

    International patients may choose Turkey for access to experienced structural heart specialists, advanced TAVI programmes, modern cardiac catheterisation laboratories, sophisticated cardiac imaging, hybrid operating facilities, and multidisciplinary heart teams.The destination should be evaluated based on hospital accreditation, patient safety standards, physician expertise, experience in TAVI, availability of advanced transcatheter valve technologies, and access to emergency cardiac surgery and comprehensive postoperative care.

    Treatment options depend on the severity of aortic valve disease, valve anatomy, symptoms, ventricular function, age, surgical risk, associated medical conditions, and overall health. Options may include:
  • Medical management of aortic valve disease
  • Transcatheter Aortic Valve Implantation (TAVI)
  • Surgical aortic valve replacement
  • Aortic valve repair in selected cases
  • Balloon aortic valvuloplasty in selected patients
  • Management of associated coronary artery disease
  • Pacemaker implantation when indicated
  • Cardiac rehabilitation
  • Long-term cardiology and valve monitoring
  • The treating multidisciplinary heart team will recommend the most appropriate treatment plan after evaluating the patient's valve anatomy, imaging findings, symptoms, heart function, surgical risk, and overall clinical condition.

    International patients may choose Turkey for access to specialised structural heart centres, experienced interventional cardiologists and cardiac surgeons, advanced cardiac imaging, modern catheterisation laboratories, transcatheter valve technologies, multidisciplinary heart teams, and structured long-term cardiac follow-up.MediGence can assist patients with hospital and specialist selection, medical record coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the patient's aortic valve condition, clinical requirements, treatment goals, surgical risk, and the hospital's expertise in Transcatheter Aortic Valve Implantation.

    Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan